BMC Rheumatol. 2025 Sep 10;9(1):104. doi: 10.1186/s41927-025-00567-y. NO ABSTRACT PMID:40931328 | DOI:10.1186/s41927-025-00567-y
Clin Rheumatol. 2025 Sep 10. doi: 10.1007/s10067-025-07684-6. Online ahead of print. ABSTRACT OBJECTIVES: IgG4-related disease (IgG4-RD) can affect multiple organ
Clin Rheumatol. 2025 Sep 10. doi: 10.1007/s10067-025-07685-5. Online ahead of print. NO ABSTRACT PMID:40931288 | DOI:10.1007/s10067-025-07685-5
Nature. 2025 Sep 10. doi: 10.1038/s41586-025-09513-x. Online ahead of print. ABSTRACT Monogenic lupus offers valuable insights into the underlying mechanisms
Cell Mol Immunol. 2025 Sep 10. doi: 10.1038/s41423-025-01346-y. Online ahead of print. ABSTRACT Type I interferon (IFN-I) is highly prevalent
Br J Haematol. 2025 Sep 10. doi: 10.1111/bjh.70148. Online ahead of print. ABSTRACT Mastocytosis is categorized into cutaneous mastocytosis (CM),
Lancet Digit Health. 2025 Sep 9:100896. doi: 10.1016/j.landig.2025.100896. Online ahead of print. ABSTRACT BACKGROUND: New-onset atrial fibrillation, a condition associated
Nat Rev Immunol. 2025 Sep 10. doi: 10.1038/s41577-025-01214-w. Online ahead of print. ABSTRACT Actin cytoskeleton remodelling drives the migration of
J Atheroscler Thromb. 2025 Sep 9. doi: 10.5551/jat.65577. Online ahead of print. ABSTRACT AIMS: In-stent restenosis (ISR) is a significant
BMJ. 2025 Sep 10;390:r1883. doi: 10.1136/bmj.r1883. NO ABSTRACT PMID:40930797 | DOI:10.1136/bmj.r1883
BMJ Open. 2025 Sep 9;15(9):e097802. doi: 10.1136/bmjopen-2024-097802. ABSTRACT INTRODUCTION: Combined vascular endothelial growth factor/programmed death-ligand 1 blockade through atezolizumab/bevacizumab (A/B)
J Atheroscler Thromb. 2025 Sep 11. doi: 10.5551/jat.65781. Online ahead of print. ABSTRACT A 79-year-old Chinese man was referred for
Bone Jt Open. 2025 Sep 11;6(9):1090-1100. doi: 10.1302/2633-1462.69.BJO-2024-0258.R1. ABSTRACT AIMS: We sought to explore staff experience of a paediatric randomized
Mech Ageing Dev. 2025 Sep 8:112112. doi: 10.1016/j.mad.2025.112112. Online ahead of print. ABSTRACT Age-related skeletal muscle decline is a major
Pediatr Exerc Sci. 2025 Sep 10:1-8. doi: 10.1123/pes.2024-0122. Online ahead of print. ABSTRACT BACKGROUND: Juvenile idiopathic arthritis is an autoimmune
AI can Dx & predict HCQ retinopathy (HR). An International, Multi-center study used retrospective data from 409 pts https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
QD Clinic: ILD, Emphysema, Both, or Neither? Dr. Janet Pope, London, Ontario discusses this case evaluation as part of https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Gout: Highlights from APLAR 2025 Dr. Sheila Reyes, The Philippines, reports on highlights and takeaways from lectures https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
CAR T Cells are everywhere, whichever conference #APLAR25 an update on practicalities and safety measures and adverse ev https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
Dr. Binit Vaidya aptly poses this slide on the gout paradox: evidence-based T2T tx exist yet many still have uncontrolle
SGLT2 inhibitors exert their anti-inflammatory effects by inhibiting activation of the NLRP3 inflammasome. Secondary a https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Wed, 09/10/2025 –
Colchicine for #gout patients with CV risk: – since it has a purely anti-inflammatory effect, risk of acute CV events
Arthritis &Rheumatology, EarlyView.
Arthritis &Rheumatology, EarlyView.
Link zu Zeitschrift … Rheumatology (EULAR/ACR) [ 19 ]. Collected demographic and clinical …
Am J Public Health. 2025 Oct;115(10):1572-1574. doi: 10.2105/AJPH.2025.308181. NO ABSTRACT PMID:40929662 | DOI:10.2105/AJPH.2025.308181
Mol Pharm. 2025 Sep 10. doi: 10.1021/acs.molpharmaceut.5c01291. Online ahead of print. NO ABSTRACT PMID:40929712 | DOI:10.1021/acs.molpharmaceut.5c01291
